Skip to main content
. 2017 Oct 24;8:191–206. doi: 10.2147/LCTT.S140491

Figure 2.

Figure 2

Kaplan–Meier plot of overall survival for patients with squamous non-small cell lung cancer (NSCLC) and those with nonsquamous NSCLC, by mutation status from initiation of second-line therapy.

Abbreviations: ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; EGFR/ALK +, positive status; Nonsq, nonsquamous; -/unk, negative/unknown status.